Zobrazeno 1 - 10
of 12
pro vyhledávání: '"María del Mar Maldonado-Montoro"'
Autor:
Mireia Tena-Garitaonaindia, Diego Ceacero-Heras, María Del Mar Maldonado Montoro, Fermín Sánchez de Medina, Olga Martínez-Augustin, Abdelali Daddaoua
Publikováno v:
Frontiers in Microbiology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/4206b19a463d4a97ac8136bfbcd0c22c
Autor:
Mireia Tena-Garitaonaindia, Diego Ceacero-Heras, María Del Mar Maldonado Montoro, Fermín Sánchez de Medina, Olga Martínez-Augustin, Abdelali Daddaoua
Publikováno v:
Frontiers in Microbiology, Vol 13 (2022)
The priority pathogen list of the World Health Organization classified Pseudomonas aeruginosa as the second top critical pathogen. Hence, the development of novel antibacterial strategies to tackle this bacterium is highly necessary. Herein we explor
Externí odkaz:
https://doaj.org/article/d28004df32bc4886a73d8ce494079beb
Autor:
Miguel Angel Calleja Hernández, Alberto Jiménez Morales, María del Mar Maldonado Montoro, Fernando Martínez Martínez, Carlos Gustavo García-Collado, Juan Enrique Martínez-de-la-Plata
Publikováno v:
Health Policy. 125:335-340
Risk-sharing agreements(RSA) allow decision-makers to manage the uncertainty associated with effectiveness and costs of treatments. Our objective was to estimate the economic impact of RSA implementation on treatment of patients diagnosed with rheuma
Association between polymorphisms in the vitamin D receptor and susceptibility to multiple sclerosis
Autor:
María Isabel Carrasco-Campos, Alberto Jiménez-Morales, Almudena Sánchez Martín, Fernando Martínez-Martínez, Maria del Carmen Ramirez-Tortosa, María del Mar Maldonado-Montoro, Laura Elena Pineda Lancheros, Miguel Ángel Calleja-Hernández, Cristina Pérez-Ramírez, Bárbara Cancela Díez
Publikováno v:
Pharmacogenetics and Genomics. 31:40-47
OBJECTIVES Multiple sclerosis (MS) is a neurodegenerative chronic inflammatory. Mutations in the vitamin D receptor (VDR) gene can substantially affect serum vitamin D levels or alter its functionality, and can consequently increase susceptibility to
Autor:
Mireia, Tena-Garitaonaindia, Diego, Ceacero-Heras, María Del Mar Maldonado, Montoro, Fermín Sánchez, de Medina, Olga, Martínez-Augustin, Abdelali, Daddaoua
Publikováno v:
Frontiers in microbiology. 13
The priority pathogen list of the World Health Organization classified
Autor:
Juan Enrique Martínez de la Plata, Abdelali Daddaoua, Alberto Jiménez Morales, Fernando Martínez Martínez, Noelia Marquez Pete, Cristina Pérez Ramírez, María del Mar Maldonado Montoro
Publikováno v:
Journal of Personalized Medicine, Vol 11, Iss 573, p 573 (2021)
Digibug. Repositorio Institucional de la Universidad de Granada
instname
Journal of Personalized Medicine
Volume 11
Issue 6
Digibug: Repositorio Institucional de la Universidad de Granada
Universidad de Granada (UGR)
Digibug. Repositorio Institucional de la Universidad de Granada
instname
Journal of Personalized Medicine
Volume 11
Issue 6
Digibug: Repositorio Institucional de la Universidad de Granada
Universidad de Granada (UGR)
Abatacept (ABA) is an immunosuppressant indicated for treatment of rheumatoid arthritis (RA). Effectiveness might be influenced by clinical RA variants and single-nucleotide polymorphisms (SNPs) in genes encoding protein FCGR2A (His131Arg) and FCGR3A
Autor:
Fernando Martínez Martínez, Fernando Fernández-Llimos, María del Carmen Ramírez Tortosa, Alberto Jiménez Morales, Antonio Sánchez Pozo, Cristina Pérez Ramírez, Noelia Marquez Pete, María del Mar Maldonado Montoro
Publikováno v:
Archives of Medical Science.
IntroductionRheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease of unknown etiology which causes progressive deterioration of the joints, leading to severe pain and functional disability. Vitamin D and its receptor (VDR) play a sig
Autor:
Noelia, Marquez Pete, María Del Mar, Maldonado Montoro, Cristina, Pérez Ramírez, Almudena, Sánchez Martín, Juan Enrique, Martínez de la Plata, Fernando, Martínez Martínez, Rafael, Caliz Caliz, Abdelali, Daddaoua, María Del Carmen, Ramírez Tortosa, Alberto, Jiménez Morales
Publikováno v:
Journal of Personalized Medicine
Abatacept (ABA) is used as a first-line treatment in patients diagnosed with moderate and severe rheumatoid arthritis (RA). The interindividual response to ABA therapy is very variable in these patients. The objective of our study was therefore to in
Autor:
Almudena Sánchez Martín, Juan Enrique Martínez de la Plata, Abdelali Daddaoua, Alberto Jiménez Morales, María del Mar Maldonado Montoro, María del Carmen Ramírez Tortosa, Rafael Caliz Caliz, Cristina Pérez Ramírez, Noelia Marquez Pete, Fernando Martínez Martínez
Publikováno v:
Digibug: Repositorio Institucional de la Universidad de Granada
Universidad de Granada (UGR)
Digibug. Repositorio Institucional de la Universidad de Granada
instname
Journal of Personalized Medicine, Vol 10, Iss 220, p 220 (2020)
Journal of Personalized Medicine
Volume 10
Issue 4
Universidad de Granada (UGR)
Digibug. Repositorio Institucional de la Universidad de Granada
instname
Journal of Personalized Medicine, Vol 10, Iss 220, p 220 (2020)
Journal of Personalized Medicine
Volume 10
Issue 4
Abatacept (ABA) is used as a first-line treatment in patients diagnosed with moderate and severe rheumatoid arthritis (RA). The interindividual response to ABA therapy is very variable in these patients. The objective of our study was therefore to in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adc1a2ff640f07e79a7e515ce5239ea9
Autor:
Alberto Jiménez-Morales, Maria del Carmen Ramirez-Tortosa, Cristina Membrive-Jiménez, Fernando Martínez-Martínez, Cristina Pérez-Ramírez, Laura Martínez-Aguilar, María Isabel Carrasco-Campos, Miguel Ángel Calleja-Hernández, Carlos García-Collado, María del Mar Maldonado-Montoro
Publikováno v:
Mutation Research/Reviews in Mutation Research. 785:108322
Treatment with interferon beta (IFNβ) is one of the first-line treatments for multiple sclerosis. In clinical practice, however, many patients present suboptimal response to IFNβ, with the proportion of non-responders ranging from 20 to 50%. This v